NEW
YORK, Jan. 8, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law
firm, is investigating potential claims related to the below-listed
proposed mergers. Kuehn Law may seek
additional disclosures or other relief on behalf of the
shareholders of these companies.
Kuehn Law is investigating
whether the Boards of the below companies 1) acted to maximize
shareholder value, 2) failed to disclose material information, and
3) conducted a fair process:
- Karuna Therapeutics, Inc. (Nasdaq: KRTX)
Bristol Myers Squibb has agreed
to acquire Karuna in a transaction valued at an estimated
$14 billion. Under the agreement,
shareholders of Karuna Therapeutics will be entitled to a payment
of $330.00 per share in cash.
- Daseke, Inc. (Nasdaq: DSKE)
Daseke has agreed to be acquired by TFI International in a cash
deal worth about $1.1 billion.
Under the proposed transaction, Daseke shareholders will receive
$8.30 per share in cash.
- RayzeBio, Inc. (Nasdaq: RYZB)
Bristol Myers Squibb has agreed
to purchase RayzeBio in an all-cash deal valued at around
$4.1 billion. In accordance with the
merger agreement, RayzeBio shareholders are set to receive
$62.50 per share in cash.
- Gracell Biotechnologies Inc. (Nasdaq: GRCL)
Under the proposed transaction AstraZeneca will purchase Gracell
for $2.00 per ordinary share in cash,
equivalent to $10.00 per Gracell ADS.
A contingent value right of $0.30 per
ordinary share (or $1.50 per Gracell
ADS) in cash will be paid upon reaching a specific regulatory
milestone.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved,
you contribute to the integrity and fairness of the financial
markets. Your investment. Your voice. Your
future.™
How to Get Involved:
Kuehn Law is dedicated to
safeguarding shareholder interests. Concerned shareholders are
encouraged to contact Justin Kuehn, Esq.,
at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not
charge its investor clients. Shareholders are advised
to act promptly, as legal rights may be time-sensitive.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-krtx-dske-ryzb-and-grcl-investors-to-contact-law-firm-302028627.html
SOURCE Kuehn Law, PLLC